Andrew Lewis

Andrew Lewis has a diverse work experience in the field of scientific research and development. Andrew is currently working as a Principal Scientist at Calla Lily Clinical Care since March 2022. Before that, they served as a Director at Alchemed Bioscience Consulting Ltd starting in January 2020. Andrew also held the position of a Royal Academy of Engineering Visiting Professor at Queen Mary University of London from October 2020.

In their previous roles, Andrew worked as a Royal Society Entrepreneur in Residence Fellow at the University of Brighton from April 2018 until April 2023. Andrew was also the Director of Research & Development at Owen Mumford Ltd from July 2020 to February 2022. Andrew held the position of VP R&D at Boston Scientific from August 2019 to January 2020.

Prior to that, Andrew had significant experience at BTG plc and Biocompatibles Uk Ltd. At BTG plc, they served as the Vice President of Research and Development from August 2017 to August 2019. Andrew also held the position of Director of Research & Development and played a significant role in the development and acquisition of the DEB Technology for liver cancer treatment.

At Biocompatibles Uk Ltd, Andrew served as the Director of Research & Technology from July 2000 to August 2011. Andrew led teams with Six Sigma methodology and focused on drug-device combinations for treating cardiovascular disease and cancer. Andrew also held various positions at Biocompatibles Ltd, including Head of Chemistry in the Biomaterials Research Group and Project Leader in the Polymer Chemistry, Cardiovascular Group.

Earlier in their career, Andrew worked as a Project Leader at Johnson & Johnson Consumer Health, where they were involved in product and process development for absorbent technologies. Andrew held this position from August 1994 to August 1996.

Overall, Andrew Lewis has a successful career in scientific research and development, with expertise in various roles and contributions to significant projects in the healthcare industry.

Andrew Lewis completed their education with a PhD in Chemistry from Aston University from 1987 to 1990. Prior to that, from 1984 to 1987, they obtained a BSc (Hons) in Combined Honours Biochemistry & Chemistry from the same institution. Andrew also holds additional certifications, including being a Chartered Scientist and a Fellow Chartered Chemist of the Royal Society of Chemistry.